Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection

Immunogenicity and safety of the BNT162b2 COVID‐19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy

(2022) Eugenio Milano et al.   JOURNAL OF MEDICAL VIROLOGY

Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia

(2022) Vladimir Petrović et al.   PLoS One

Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China

(2022) Xiaojie Huang et al.   Viruses-Basel

Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection

(2022) Ariel Israel et al.   Vaccines

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

(2022) Zabrina L. Brumme et al.   npj Vaccines

SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays

(2021) Gregory J. Walker et al.   Viruses-Basel

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

(2021) Adam K. Wheatley et al.   Nature Communications

Assessment of salivary antibody response to BNT162b2 mRNA COVID‐19 vaccination

(2021) Ivana Lapić et al.   JOURNAL OF MEDICAL VIROLOGY

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

(2021) Jerald Sadoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study

(2021) Matthew A Spinelli et al.   Lancet HIV

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV

(2021) Jake A. Ruddy et al.   AIDS

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

(2021) Bezawit A Woldemeskel et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1

(2021) Itzchak Levy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antibody titers and protection against a SARS-CoV-2 infection

(2021) Chloé Dimeglio et al.   JOURNAL OF INFECTION

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

(2021) Hana M. El Sahly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human IgG and IgA responses to COVID-19 mRNA vaccines

(2021) Adam V. Wisnewski et al.   PLoS One

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

(2021) Kizzmekia S. Corbett et al.   SCIENCE

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

(2021) Pinja Jalkanen et al.   Nature Communications

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

(2021) Matthias Becker et al.   Nature Communications

Brief Report: Humoral and cellular immune responses to SARS‐CoV‐2 infection and vaccination in B cell depleted autoimmune patients

(2021) David Simon et al.   Arthritis & Rheumatology

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

(2021) John Frater et al.   Lancet HIV

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

(2021) Shabir A Madhi et al.   Lancet HIV

Humoral response to SARS-CoV-2 vaccines in people living with HIV

(2021) Sebastian Noe et al.   INFECTION

Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV

(2021) Zhengchao Lv et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

(2021) Mark A Brockman et al.   JOURNAL OF INFECTIOUS DISEASES

Developing an Optical Interferometric Detection Method based biosensor for detecting specific SARS-CoV-2 immunoglobulins in Serum and Saliva, and their corresponding ELISA correlation

(2021) A.M.M. Murillo et al.   SENSORS AND ACTUATORS B-CHEMICAL

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV

(2021) Aljawharah Alrubayyi et al.   Nature Communications

Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS‐CoV ‐2 in an unvaccinated cohort

(2021) David Simon et al.   Arthritis & Rheumatology

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients

(2021) Lorenzo Azzi et al.   EBioMedicine

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies

(2020) Kathleen G. Beavis et al.   JOURNAL OF CLINICAL VIROLOGY

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

(2020) Chee Wah Tan et al.   NATURE BIOTECHNOLOGY

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

(2020) David Simon et al.   Nature Communications

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

(2020) Ugur Sahin et al.   NATURE

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhanced SARS-CoV-2 neutralization by dimeric IgA

(2020) Zijun Wang et al.   Science Translational Medicine

ELISA detection of SARS-CoV-2 antibodies in saliva

(2020) Melanie A. MacMullan et al.   Scientific Reports

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

(2020) Carlo Cervia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

(2019) Antigoni Morou et al.   NATURE IMMUNOLOGY

Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living with and without HIV in the Veterans Aging Cohort Study

(2018) Kellie L. Hawkins et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Immune reconstitution and vaccination outcome in HIV-1 infected children

(2012) Alberto Cagigi et al.   Human Vaccines & Immunotherapeutics

Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy

(2009) Alessandra Viganò et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count

(2009) Michael L. Landrum et al.   VACCINE